Skip to main content
Clinical Trials/NCT06057337
NCT06057337
Recruiting
N/A

Promoting Health and Reducing Risk Among Hispanic Sexual Minority Youth and Their Families

University of Miami1 site in 1 country306 target enrollmentMarch 11, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
University of Miami
Enrollment
306
Locations
1
Primary Endpoint
Change in quantity of drug use
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

This study will evaluate the effects of a parenting intervention for Hispanic sexual minority youth in preventing/reducing drug use and depressive symptoms. It will also examine whether the intervention improves parent social support for the adolescent, parent acceptance, family functioning, and whether it reduces general stress and stress associated with being a Hispanic sexual minority.

Registry
clinicaltrials.gov
Start Date
March 11, 2024
End Date
December 28, 2029
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Guillermo Prado

Professor

University of Miami

Eligibility Criteria

Inclusion Criteria

  • Youth, 13 - 19, who report at least one of the following: a) identify as gay, lesbian, or bisexual, or b) reports same-sex sexual behavior.
  • Adolescent has their disclosed their sexual minority status to at least one parent.
  • Adolescent is of Hispanic immigrant origin, defined by having at least one parent that self-identifies as Hispanic (English and Spanish speaking Hispanics can participate in the study).
  • Adolescent lives with an adult parent who is willing to participate.
  • Family lives in South Florida

Exclusion Criteria

  • Adolescent identifies as transgender.
  • Family plans to move out of South Florida during the study period

Outcomes

Primary Outcomes

Change in quantity of drug use

Time Frame: Baseline up to 30 months

Change in drug use will be reported as the amount of use over the previous 90 days at each timepoint.

Change in frequency of drug use

Time Frame: Baseline up to 30 months

Change in drug use will be reported as the number of days of use over the previous 90 days at each timepoint.

Change in depression symptoms

Time Frame: Baseline up to 30 months

Change in depression symptoms will be assessed with the Center for Epidemiological Studies Depression Scale. Scores range from 0 to 60 with higher scores indicating the presence of more symptoms.

Secondary Outcomes

  • Change in Family Functioning as assessed by the Parenting Practices Questionnaire(Baseline up to 30 months)
  • Change in unprotected sexual behavior(Baseline up to 30 months)
  • Changes in Parent Acceptance of Adolescents Sexual Orientation as assessed by the Perceived Parental Reactions Scale(Baseline up to 30 months)
  • Changes in Adolescent Stress as assessed by the Perceived Stress Scale(Baseline up to 30 months)
  • Change in Family Functioning as assessed by the Parent-Adolescent Communication Scale(Baseline up to 30 months)
  • Changes in Sexual Minority Stress as assessed by the Sexual Minority Adolescent Stress Scale(Baseline up to 30 months)

Study Sites (1)

Loading locations...

Similar Trials

Families With Pride ("Familias Con... | Clinical Trial